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MicroRNA107 (Mir107) has been thought to relate to the brain structure phenotype of
Alzheimer’s disease. In this study, we evaluated the cortical anatomy in amnestic mild
cognitive impairment (aMCI) and the relation between cortical anatomy and plasma levels
of Mir107 and beta-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1).
Twenty aMCI (20 aMCI) and 24 cognitively normal control (NC) subjects were recruited,
and T1-weighted MR images were acquired. Cortical anatomical measurements,
including cortical thickness (CT), surface area (SA), and local gyrification index (LGI),
were assessed. Quantitative RT-PCR was used to examine plasma expression of Mir107,
BACE1 mRNA. Thinner cortex was found in aMCI in areas associated with episodic
memory and language, but with thicker cortex in other areas. SA decreased in aMCI
in the areas associated with working memory and emotion. LGI showed a significant
reduction in aMCI in the areas involved in language function. Changes in Mir107 and
BACE1 messenger RNA plasma expression were correlated with changes in CT and
SA. We found alterations in key left brain regions associated with memory, language,
and emotion in aMCI that were significantly correlated with plasma expression of Mir107
and BACE1 mRNA. This combination study of brain anatomical alterations and gene
information may shed lights on our understanding of the pathology of AD.
Clinical Trial Registration: http://www.ClinicalTrials.gov, identifier NCT01819545.
Keywords: Alzheimer’s disease, amnestic mild cognitive impairment, genetics, biological markers, surface-based
morphometry
INTRODUCTION
Alzheimer’s disease (AD) is characterized by a progressive decline in cognition and daily
function. It is the most common form of dementia worldwide. Pathologically, AD is defined
by the intracellular accumulation of aggregated and hyperphosphorylated tau protein, the
extracellular deposition of amyloid β (Aβ) peptides, and the accumulation of neurofibrillary
tangles and amyloid plaques throughout the cortex (De Strooper, 2010; Kandimalla et al., 2013a,b).
Amnestic mild cognitive impairment (aMCI) is thought to be a predementia phase of AD (Albert
et al., 2011), and is characterized by the same etiology to a lesser degree (Petersen et al., 2006).
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A widely accepted hypothesis links the major pathology of AD
to the generation and subsequent accumulation of Aβ through
sequential cleavage of amyloid precursor protein (APP) by beta-
site APP cleaving enzyme 1 (BACE1)1 and γ-secretase (Dislich
and Lichtenthaler, 2012). Regulation of expression of the proteins
involved in this process plays an important role in AD (Bettens
et al., 2009).
BACE1 expression is regulated by BACE1 messenger
RNA (BACE1 mRNA), while BACE1 mRNA is regulated by
microRNA (Mir/miRNA). Accumulating evidence suggests that
alterations in Mirs contribute to AD (Sathya et al., 2012).
Studies have found decreases in Mirs in postmortem brain of
AD patients, as compared to normal controls (NCs). More
interestingly, Mir expressions are altered not only in the
brains of AD patients, but also in their cerebral spinal fluid
(CSF) and blood plasma (Hébert et al., 2010). Among these,
MicroRNA107 (Mir107)2 targets genes directly related to AD,
including BACE1. In microarray studies, Mir107 levels were
substantially reduced in the temporal cortex of AD patients
(Wang et al., 2011).
The accumulation of neurofibrillary tangles and amyloid
plaques in the cortex is associated with gray matter (GM)
atrophy and volume decline. Abnormal brain anatomy has been
identified as an important feature of the pathophysiological
process of AD, and can be visualized using different modalities of
MRI for GM (Meda et al., 2013) and white matter (Li et al., 2013;
Jin et al., 2015;Wang et al., 2016), respectively. Those features can
be accurately used to differentiate AD patients from the normally
aging population (Zhan et al., 2014, 2015). Morphological
parameters have been widely used to detect brain abnormalities
in aMCI. Previous voxel-based morphometry (VBM) studies
reported that aMCI subjects showed GM atrophy in entorhinal
cortex, posterior cingulate cortex, and medial prefrontal cortex
(Apostolova et al., 2007). AlthoughVBM is valuable inmeasuring
morphological changes in AD patients, it does not capture
cortical sulcal and gyral patterns, or their changes due to the
disease (Davatzikos, 2004).
Surface-based morphometry (SBM) is one approach that
captures subtle cortical surface changes, and can examine
cortical thickness (CT) and surface area (SA) of GM separately.
Studies have reported that aMCI patients showed overall cortical
thinning and sulcal widening, compared to NCs (Davatzikos,
2004). SBM can also assess the degree of cortical folding using
local gyrification index (LGI; Im et al., 2008; Li et al., 2014a).
These measurements provide unique and complementary
information that reflects distinct cortical properties (Li et al.,
2014b; Libero et al., 2014). Investigation of these surface-based
measures can provide information beyond those volumetric
abnormalities previously uncovered in AD. By measuring CT,
SA, and LGI, we may uncover the underlying changes in cortical
architecture of AD (Libero et al., 2014).
A definite diagnosis of AD is determined by postmortem
examination. Currently, amyloid PET examination (Fleisher
et al., 2012) can be utilized for early diagnosis, but, because PET
1http://www.informatics.jax.org/marker/MGI:1346542
2http://www.informatics.jax.org/marker/MGI:3619063
examination is expensive, a routine diagnosis of aMCI and AD
still depends on combination of clinical and neuropsychological
tests. Therefore, there is great interest in identifying AD genotype
and phenotype associated biomarkers in brain anatomy and
plasma.
Our goal in this study is to investigate alterations in
cortical anatomy in aMCI, as well as to detect any relationship
between structural changes and neuropsychological scores,
levels of Mir107, and BACE1 mRNA in plasma. The findings
of this study will provide valuable information about the
abnormal neuroanatomy of aMCI, and also highlight a potential
connection between structural changes and plasma Mir107 and
BACE1 mRNA.
MATERIALS AND METHODS
Participants
This study was registered as a clinical trial with ClinicalTrials.gov
registry number as NCT018195453. We recruited 20 patients
with aMCI from the Shanghai Mental Health Center, Shanghai
Jiao Tong University School of Medicine, and 24 cognitively
normal elderly subjects from the Shanghai Changning District.
Patients were enrolled by the hospital via self-referral or the
referral from family or physician. This study was approved by
the Institution’s Ethical Committee of Shanghai Mental Health
Center, Shanghai Jiao Tong University School of Medicine,
and written informed consent was obtained from all subjects
and/or their legal guardians. All experiments were performed in
accordance with relevant guidelines and regulations.
aMCI was diagnosed based on the previously published
criteria (McKhann et al., 2011). We amended the aMCI
diagnostic criteria of the Petersen Mini Mental States
Examination (MMSE; Folstein et al., 1975) in order to
accommodate the low level of education in elderly Chinese.
In the current study, we used revised MMSE cut-off scores
as one of the criteria to recruit individual subjects (Katzman
et al., 1988). The cognitively normal elderly control subjects
(NC) were also recruited. They were independently functioning
community dwellers with no neurological or psychiatric
conditions.
All participants underwent a screening process that
included a review of their medical history, physical and
neurological examinations, laboratory tests, and MRI scans.
The clinical assessment of MCI or dementia included
neuropsychological tests, as well as behavioral and psychiatric
interviews conducted by the attending psychiatrists. MMSE
and Montreal Cognitive Assessment (MoCA; Nasreddine et al.,
2005) were assessed in all participants. Based on assessment,
aMCI patients were retained, and others who had impairments
in a single non-memory domain or impairment in two or more
domains were excluded.
MR Image Acquisition and Processing
MRI images were scanned with a Siemens MAGNETOM
VERIO 3T scanner (Siemens,Munich). T1-weighted images were
3www.clinicaltrials.gov
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TABLE 1 | The sequence of primers used for the RT-PCR of BACE1 mRNA
and Mir107.
Gene Primer sequence Annealing Lengths of
temperature PCR
(◦C) products (bp)
BACE1 F:5′AAGTTCATTACCTCCCTATCAGT3′ 60 186
mRNA R:5′AGGCCCTCCTTGTATTTCC3′
Mir107 GSP:5′GCAGCAGCATTGTACAGG3′ 60 65
R:5′CAGTGCGTGTCGTGGAGT3′
obtained with 128 sagittal slices using the 3D magnetization
prepared rapid acquisition gradient echo sequence with the
following parameters: TR = 2530 ms, TE = 3.39 ms, flip
angle = 7◦, spatial resolution = 1 × 1 × 1.3 mm3, and
the acquisition time was 8 min 7 s. The MRI FLAIR data
acquisition setting used the following parameters: matrix
256 × 192, NEX = 1, FOV = 24 cm, TE = 140, TR = 8600,
InVTime = 2200.
Surface anatomy was extracted from MR images using
FreeSurfer software package (version 5.3.0)4 (Fischl and
Dale, 2000). We reviewed all obtained cortical surfaces and
minimal manual editing was also performed at inaccurately
segmented locations. The generated cortical surfaces were
validated by comparing them with manual measures on
MRI data (Fischl and Dale, 2000). CT was computed as
the average distance between gray-white surface and pial
surface. SA for each vertex was calculated on the pial
surface, representing the area of the tessellated triangles
linked to the vertex. The local cortical folding for each
vertex was measured with LGI, which accounted for
the ratio of local SA to the outer hull layer that tightly
wrapped the pial surface. The folding was extended from
two-dimensional gyrification measurement (Schaer et al.,
2008).
Blood Plasma Collection
Blood samples were obtained from each subject and were
centrifuged for 20 min at 4◦C at 3000 rpm. A 200 µl plasma
aliquot was taken from each sample and immediately frozen and
stored at−80◦C.
Quantitative RT-PCR (qRT-PCR)
Total mRNA and miRNA were extracted using TRIZOLr
Reagent (Invitrogen, Carlsbad, CA, USA), and were quantified
using a NanoDropr ND-1000 spectrophotometer (Waltham,
MA, USA). Total mRNA was subjected to qRT-PCR using
2× PCR master mix (Super Array, Valencia, CA, USA)
and the ABI PRISM7900 system (Applied Biosystems,
Foster City, CA, USA). For each sample, real-time PCR
was performed for the target mRNA (BACE1; Table 1)
together with the reference gene β-actin. The relative
expression of the target mRNA was determined by the 2∆∆CT
method.
4http://surfer.nmr.mgh.harvard.edu/
Total miRNA qRT-PCR was conducted using the Universal
cDNA Synthesis Kit (Exiqon, Vedbaek, Denmark) and the
Gene Amp PCR System 9700 (Applied Biosystems, Foster
City, CA, USA). Similarly, for each sample, real-time PCR
was performed for the target Mir107 (Table 1) together
with the reference gene microRNA423–5p. The relative
expression of the target miRNA was determined by the 2∆∆CT
method.
BACE1 Protein Concentration
We used a BACE1 protein ELISA kits (LBLr 27752
human BACE1 assay kit, Takasaki-Shi, Gunma, Japan) to
assay the BACE1 protein concentration from our study
participants.
Statistical Analysis
SPSS 17.0 was used for statistical analysis. Two-tailed t-tests
were used to compare demographic characteristics between
groups. Chi-square tests were used to measure differences in
gender distribution. For each vertex, a general linear model
was used to detect significant differences in CT, SA, and
LGI between aMCI and controls patients, respectively. The
confounding factors were regressed, including age, gender,
education, and overall measurement. A smoothing kernel of
10 mm was applied before group comparison at the level
of each vertex. Mir107, BACE1 mRNA, and BACE1 protein
expression between groups were analyzed by two-tailed t-tests.
Pearson correlation was used to examine correlations between
plasma Mir107 and BACE1 mRNA expression and cortical
anatomy.
RESULTS
Demographic and Clinical Variables
The demography and clinical scores for the aMCI group
and the NC group are listed in Table 2. No significant
differences between the groups were observed in age,
gender or education, so the effects of age, gender, education
level, and brain size were removed in our analysis. As
expected, there were group differences in the MMSE,
MoCA and Clinical Dementia Rating-Sum of Box (CDR-SOB)
scores.
Mir107, BACE1 mRNA, and Protein Level in
Plasma
Plasma levels of Mir107 and BACE1 mRNA were significantly
different between aMCI and NC (Table 2). There were
significant negative correlations between plasma Mir107 and
BACE1 mRNA gene expression in aMCI and NC (Table 2).
We did not find any significant difference in the plasma
level of BACE1 protein between aMCI and NC subjects
(Table 2).
Cortical Thickness
Samples from patients with aMCI showed widespread thinning
of CT as compared to NC in the memory-associated cortical
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TABLE 2 | Demography, clinical scores, RT-PCR of Mir107, BACE1 mRNA, and protein expression in plasma of the subjects in the study.
95% CI of the Mean difference
aMCI (n = 20) NC (n = 24) p-value Mean difference Lower Upper
Age (years) 70.1 ± 7.2 69.9 ± 7.6 0.81 0.18 −4.34 4.7
Male/Female 9/11 13/11 0.55 – –
Education (years) 7.8 ± 4.9 9.4 ± 4.1 0.91 −1.58 −4.32 1.17
MMSE 24.5 ± 3.4 27.8 ± 2.8 <0.001 −3.25 −4.96 −3.25
MoCA 18.3 ± 4.3 24.0 ± 3.6 <0.001 −5.73 −8.2 −3.25
CDR-SOB 2.0 ± 0.7 0.0 ± 0.0 <0.001 2 1.67 2.34
Mir1071 2.33 ± 2.24 3.85 ± 1.24 0.007 −1.52 −2.6 −0.44
BACE1mRNA2 1.25 ± 0.50 0.88 ± 0.37 0.007 0.37 0.11 0.63
BACE1 (LINE) 3.95 ± 1.82 3.22 ± 1.07 0.106 0.73 −0.16 1.62
BACE1 (LOG) 4.91 ± 1.85 4.17 ± 1.25 0.122 0.74 −0.21 1.69
r (1 and 2) −0.761 −0.648 – – – –
p-value (1 and 2) <0.001 0.001 – – – –
Data represent mean ± SD and were analyzed by t-test; the p-values were determined from two-tailed t-tests except for gender, which was analyzed using the Chi
squared test; 1 = Mir107, 2 = BACE1 mRNA, Pearson Correlation analysis; Symbol: – denotes Not Applicable.
areas. CT was thinner in the superior parietal gyrus, postcentral
gyrus, lingual gyrus, and paracentral gyrus, compared to other
brain regions both in aMCI and NC subjects (Figure 1A).
There was significant difference within the aMCI patients with
increased age (p = 0.014), but similar changes were not seen in
the NC subjects (Figure 1B). Left brain areas associated with
episodic memory and language showed the largest differences
(p < 0.05) between the groups in left postcentral gyrus, left
inferior parietal gyrus, left precuneus, and the upside right
supramarginal gyrus. In addition, the left superior temporal
gyrus and insula, as well as the low side right supramarginal
fusiform gyrus, were significantly thicker in aMCI (p < 0.05,
Figure 1C).
Cortical Surface Area
There was no significant change between two groups in total
SA, but aMCI patients showed reduced SA with the increased
age when compared to NC. SA was reduced in the superior
parietal gyrus, postcentral gyrus, middle temporal gyrus, and
anterior cingulate gyrus in general (Figure 2A). There was
no significant difference between aMCI and NC with the
increased age (Figure 2B). ROI-based group analysis found
the significantly reduced SA in left superior frontal gyrus,
right supramarginal and caudal middle frontal gyrus, and right
posterior cingulate gyrus in aMCI (p < 0.05). In addition,
left postcentral gyrus had the significantly larger SA in aMCI
(p< 0.01, Figure 2C).
Local Gyrification Index
The aMCI group had significantly lower LGI in general. LGI
was higher in the superior temporal gyrus and middle temporal
gyrus than other brain regions in both groups (Figure 3A).
aMCI showed reduced LGI with increase of age; a significant
difference was found between groups (p = 0.038). There was
also a significant decrease with the increased age within aMCI
(p = 0.046, Figure 3B). The ROI-based LGI group analysis
showed a significant effect in the right superior temporal gyrus
(p< 0.05) in aMCI (Figure 3C).
Abnormal Surface Anatomy,
Neuropsychological Scores, and Plasma
Mir107 and BACE1
Changes in CT in aMCI were correlated with neuropsychological
scores and plasma Mir107 expression (Figure 4A). Left
postcentral gyrus CTwas correlated withMMSE andMoCA. Left
inferior parietal gyrus and precuneus cortex CT were correlated
withMMSE andMoCA, as well as plasmaMir107. Right superior
supramarginal gyrus CT was correlated with MMSE, while the
right inferior supramarginal gyrus was negatively correlated with
MoCA. Right fusiform gyrus CT was negatively correlated with
MMSE and MoCA (Figure 4A).
Changes in aMCI SA were also correlated with
neuropsychological test scores and plasma Mir107 and
BACE1 mRNA expression (Figure 4B). SA of the left
superior frontal gyrus was positively correlated with plasma
Mir107 expression and negatively correlated to plasma
BACE1 mRNA expression. SA of the right supramarginal
gyrus, right caudal middle frontal gyrus, and right posterior
cingulate cortex were positively correlated to MoCA
(Figure 4B). We also found significant reduction in LGI
in the right superior temporal gyrus in aMCI, which was
correlated with MMSE (p = 0.009) and MoCA (p = 0.028,
Figure 4C).
DISCUSSION
The main goal of this study is to investigate changes in
cortical anatomy in aMCI patients, especially on CT, SA, and
LGI, and also to determine any correlation between structural
changes and Mir107 and BACE1 plasma levels. The results
obtained demonstrate a correlation between CTs of left precuneus
cortex and left inferior parietal gyrus and plasma levels of
Mir107, and between SA of left superior frontal gyrus and
plasma levels of Mir107 and BACE1 mRNA. We hypothesize
that the left precuneus cortex, left inferior parietal gyrus, and
left superior frontal gyrus are the areas first damaged in
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FIGURE 1 | (A) The cortex thicknesses are thinner in the superior parietal gyrus, postcentral gyrus, lingual gyrus and paracentral gyrus than other brain regions both
in amnestic mild cognitive impairment (aMCI) and normal control (NC) in general. (B) aMCI shows less cortical thickness (CT) than NC when age increases but no
significant difference is found between groups (p = 0.122). There is significant difference within group of aMCI when age increases (p = 0.014), while there is no
significant difference within group of NC when age increases (p = 0.747). (C) The ROI-based analysis of CT revealed that the left postcentral gyrus (PoCG.L), the left
inferior parietal gyrus (IPG.L), the left precuneus (PCUN.L) and the upside right supramarginal gyrus (SMG.RU) were significant group differences (p < 0.05) between
the aMCI and the NC groups with the aMCI having thinner cortex than the NC. In addition, the left superior temporal gyrus (STG.L), the left insula (INS.L), the low side
right supramarginal gyrus (SMG.RL) and the right fusiform gyrus (FFG.R) exhibited significantly (p < 0.05) larger thickness in the aMCI compared with the NC.
aMCI, and form the core regions of AD impairment. We also
hypothesize that Mir107 is critical to the structural changes in
AD brain cortex that are associated with cognition, language,
and emotion.
Alterations in Cortical Thickness
We found that CT, especially the CT of left heteromodal
association, was thinner in aMCI patients than in NC. CT is
impacted by proliferation of myelin, a reduction in neuronal
size or number, and changes in synapses (Sowell et al.,
2004). CT is also influenced by the number and size of
cells within a column, packing density, and by the extent of
myelination (Eickhoff et al., 2005). Thus, alterations in CT
may reflect abnormality in the underlying cell counts and
organization.
Decreased CT in the left postcentral gyrus, left inferior parietal
gyrus, and left precuneus cortex found in this study is in line
with previous studies of aMCI, in which late aMCI showed
cortical thinning in the bilateral dorsolateral prefrontal, anterior
andmedial temporal, and temperoparietal association cortices, as
well as the precuneus (Ye et al., 2014). We found increased cortex
thickness in the left superior temporal gyrus cortex, left insula,
low side right supramarginal gyrus, and right fusiform gyrus in
aMCI. These areas are associated with social cognition processes
and word recognition. Some compensations probably occur in
the onset of early AD stage.
Some CT results suggest that thinning of heteromodal
association cortices is an early biomarker of AD, not
hippocampal loss (Sabuncu et al., 2011). We did not find
significant hippocampal volume loss in aMCI; instead, we found
changes in the heteromodal association cortices, such as left
inferior parietal gyrus and left precuneus cortex. Researchers
have also reported that AD patients had the reduced CT
bilaterally in the precuneus, which is characteristic of AD
pathology (Watson et al., 2015). The precuneus is important
for the recall of episodic memories, and is involved in source
memory with the left inferior prefrontal cortex (Sadigh-Eteghad
et al., 2014). The role of the precuneus is suggested to provide
the rich episodic contextual associations used by the prefrontal
gyrus to select correct memories (Sadigh-Eteghad et al., 2014). In
recollection, the precuneus seems to determine whether context
information exists, and therefore could be involved in diverse
processes as episodic memory retrieval, working memory, and
conscious perception.
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FIGURE 2 | (A) There is no significant difference between two groups on the total surface area (SA). But aMCI shows less SA than NC when age increases. The
surface areas are less in the superior parietal gyrus, postcentral gyrus, middle temporal gyrus and anterior cingulate gyrus than other brain regions both in aMCI and
NC in general. (B) aMCI shows less SA than NC when age increases but no significant difference is found between groups (p = 0.567). There are no significant
difference within group of aMCI (p = 0.847) and NC (p = 0.524) when age increases, respectively. (C) ROI based group analysis found significantly (p < 0.05) smaller
SA in the left superior frontal gyrus (SFG.L), the right supramarginal gyrus (SMG.R), the right caudal middle frontal gyrus (CMFG.R) and the right posterior cingulate
gyrus (PCG.R) in the aMCI, compared with the NC. In addition, the left postcentral gyrus (PoCG.L; p < 0.01) exhibited significantly larger SA in the aMCI compared
with the NC.
Our findings are consistent with the Pittsburgh Compound-B
(PIB) and Fluorodeoxyglucose—Positron Emission Tomography
(FDG-PET) imaging studies. For example, AD patients showed
significant PIB retention in the bilateral precuneus, temporal
lobe, and cingulate gyrus, as well as glucose hypometabolism
in these areas as well as the inferior parietal and middle
frontal gyrus, left precentral and parahippocampal gyrus, right
superior frontal gyrus, and thalamus (He et al., 2015). The
results seen in our study are in line with previous studies of
aMCI. We conclude from these findings that structural changes
may occur at the onset of aMCI, and can be detected by CT
assessment.
Alterations in Surface Area
We found reduced SA in the left superior frontal gyrus, right
supramarginal gyrus, right caudal middle frontal and right
posterior cingulate gyrus in aMCI. A few prior studies have
examined SA in aMCI with rather inconsistent results. The
SA regions implicated in aMCI and NC include the superior
temporal gyrus, lingual gyrus, and superior frontal gyrus in
the left hemisphere, as well as the angular gyrus, lateral
orbitofrontal sulcus, inferior parietal sulcus, middle frontal
rostral region, pars triangularis gyrus, central sulcus, temporal
pole, superior temporal sulcus, and the precentral gyrus in the
right hemispheres (Li et al., 2014b). Another study found the SA
in progressive aMCI was slightly greater than in AD (Liao et al.,
2014), but with lower cortical GM surface areas in left superior
temporal, supramarginal, and inferior parietal cortices (Madsen
et al., 2015).
SA has been previously found to be strongly positively
correlated with head size and brain size (Dickerson et al., 2009),
and is also related to the number of minicolumns in cortex, as
the SA of an area is driven by the number of columns. This
is important considering the increased number of minicolumns
in the frontal and temporal areas in aMCI (Casanova et al.,
2010). Thus, alterations in SA in aMCI may be explained by
abnormal minicolumn counts, or overall differences in brain
size.
Alterations in Cortical Folding
Sulcal folds are the principal surface landmarks of the cerebral
cortex, and exhibit structurally complex patterns that are
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FIGURE 3 | (A) Compared with controls, aMCI has significant difference on the general local gyrification index (LGI) and one cluster where aMCI has significant LGI
reduction. The LGI are higher in the superior temporal gyrus, and middle temporal gyrus than other brain regions both in aMCI and NC in general. (B) aMCI shows
less CT than NC when age increases and significant difference is found between groups (p = 0.038). There is significant difference within group of aMCI when age
increases (p = 0.046), while there is no significant difference within group of NC when age increases (p = 0.349). (C) The ROI based LGI group analysis shows a
significant effect of the right superior temporal gyrus (STG.R; p < 0.05) in aMCI.
postulated to reflect underlying connectivity (Van Essen, 1997).
Changes in folding geometry have been shown to develop with
aging and to be associated with cognitive decline (Kochunov
et al., 2005; Liu et al., 2011). Sulcal of individuals with MCI
and AD had less curvature and depth than those of cognitively
NCs (Im et al., 2008). These differences were observed to be the
largest in the temporal lobe. Cognitive functioning, as assessed by
MMSE scores, decreased as global cortex gyrification decreased.
Abnormalities of global cortex gyrification and regional sulcal
span are characteristic of patients with even mild AD and they
may thus facilitate early diagnosis of this condition (Liu et al.,
2012).
There are reports of mild AD patients with lower gyrification
index than controls (King et al., 2010). A consistent pattern
of gyrification changes was seen also in dementia subjects,
with regions generally affected early in the progression of
AD pathology for decreased gyrification (Lebed et al., 2013).
We found a reduction in global gyrification in aMCI.
A previous study found sulcal widening in AD in the
frontal, parietal, temporal, and occipital lobes (Im et al.,
2008). Our present study found AD-associated widening
of individual sulcal within brain lobes, particularly in the
superior frontal and superior temporal sulcal. We suspect
the right superior temporal gyrus may be a contributor to
the AD effects observed. The gyrification of right superior
temporal gyrus in the controls and aMCI patients was reported
to be positively associated with MMSE and MoCA scores,
supporting previous associations between cognitive performance
and cortical morphology in elderly individuals (Liu et al.,
2011).
Plasma Levels of Mir107 and BACE1
mRNA and Abnormal Cortical Anatomy
There was a significant change in Mir107 and BACE1 mRNA in
the plasma samples from aMCI and NC subjects, suggesting that
plasma Mir107 and BACE1 mRNA expression may be linked to
the decrease in CT in the precuneus and cortical SA of the left
superior frontal gyrus. Evidence has suggested that the alterations
of miRNAs could contribute to AD risk (Hébert et al., 2010). The
study has demonstrated that specific miRNA levels were altered
in the brains, CSF, and plasma of AD patients (Hébert et al.,
2010), raising the possibility of using these compartments for
diagnosis.
A combination of genetic data and neuroimaging techniques
is increasingly becoming a winning strategy in identifying
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FIGURE 4 | The relationship between brain regions with abnormal surface anatomy in aMCI and neuropsychological test scores and the plasma
target gene expressions. Changes in CT, SA and LGI in aMCI were correlated with neuropsychological scores and/or plasma MiRNA 107 expression. (A) The
relationship of CT with neuropsycological test score and the plasma expression of MiRNA 107. (B) The relationship of SA with neuropsycological test score and the
plasma expression of MiRNA 107 and BACE1 mRNA. (C) The relationship of local gyrification and neuropsycological test score.
preclinical stages of AD. By MRI, FDG-PET, and amyloid
PET, characteristics of AD can be detected in clinically normal
subjects who are genetically predisposed to the disease. In
particular, presenilin-1 mutation carriers with aMCI have
smaller brain volumes in the thalamus, splenium and pons, and
originally involve with the left temporal lobe (Lee et al., 2013).
Frontiers in Aging Neuroscience | www.frontiersin.org 8 May 2016 | Volume 8 | Article 112
Wang et al. Abnormal Brain Anatomy and Mir107 in aMCI
Apolipoprotein E genotype and family history also have an
independent and/or additive contribution to brain structural
changes (Honea et al., 2010).
In this study, we demonstrate for that peripheral Mir107
and BACE1 mRNA levels were associated with abnormal brain
cortical anatomy, including the decrease in CT of precuneus
cortex and in SA of left superior frontal gyrus in aMCI patients.
These finding suggest that peripheral Mir107 and BACE1mRNA
can be a candidate of early biomarkers for AD and may be
important for the onset of AD. We also found that the plasma
level of Mir107 was altered in the same fashion as plasma
BACE1 mRNA, suggesting that Mir107 may be central in the
pathogenesis of AD. This combination study of brain anatomical
disruption and gene information, to our knowledge, has not been
attempted previously and may shed light on our understanding
of pathology of AD beyond amyloid protein theory. In the
future, we will continue acquiring MRI scans with more subjects
and will conduct a larger population study to further explore
this topic.
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